✦ LIBER ✦

Vincristine, cisplatin, teniposide, and cyclophosphamide combination in the treatment of recurrent or metastatic adrenocortical cancer

✍ Scribed by Tanweera S. Khan; Anders Sundin; Claes Juhlin; Erik Wilander; Kjell Öberg; Barbro Eriksson

Book ID: 111640970
Publisher: Springer US
Year: 2004
Tongue: English
Weight: 128 KB
Volume: 21
Category: Article
ISSN: 1357-0560
DOI: 10.1385/mo:21:2:167

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of refractory or recurrent sma

Treatment of refractory or recurrent small cell lung cancer (SCLC) with cyclophosphamide, cisplatin and vincristine (a non-cross-resistant regimen)

✍ Cardenal, F.; García del Muro, X.; Verdaguer, R. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Combination cyclophosphamide, adriamycin

Combination cyclophosphamide, adriamycin, and vincristine rapidly alternating with combination cisplatin and VP-16 in treatment of small cell lung cancer

✍ Ronald B. Natale; Brenda Shank; Basil S. Hilaris; Robert E. Wittes 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 750 KB

Combination cyclophosphamide, adriamycin

Combination cyclophosphamide, adriamycin, and vincristine rapidly alternating with combination cisplatin and VP-16 in treatment of small cell lung cancer

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 100 KB

VM-26-vincristine-cisplatin combination

VM-26-vincristine-cisplatin combination chemotherapy in the treatment of primary advanced and recurrent endometrial carcinoma

✍ B Sorbe; E Wolmesjo; B Frankendal 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Feasibility study of intraarterial vs in

Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors

✍ David J. Stewart; Zvonimir Grahovac; Herman Hugenholtz; Vasco DaSilva; Michael T 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 720 KB

Sequential multiagent chemotherapy incor

Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer

✍ Richard L. Theriault; Gabriel N. Hortobagyi; Shu W. Kau; Frankie A. Holmes; Vere 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

Forty-three consecutive patients with metastatic breast cancer and clearly measurable disease were treated with sequential multiagent chemotherapy. Therapy consisted of the administration in fixed sequence of cisplatin, doxorubicin, and cyclophosphamide (PAC) (four cycles), vinbbtine, doxorubicin, a